Characteristics of people with epilepsy in three Eastern African countries - a pooled analysis.
Epilepsy
Global health
Sub-Saharan Africa
Treatment gap
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
26 Aug 2022
26 Aug 2022
Historique:
received:
15
04
2022
accepted:
20
07
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
31
8
2022
Statut:
epublish
Résumé
Epilepsy is one of the most common neurological disorders worldwide. Yet, its treatment gap is large in some areas and especially in sub-Saharan Africa data on clinical, radiological and semiological characteristics, as well as on treatment of persons with epilepsy (PWE) are still scarce. We pooled data from four cross-sectional studies on epilepsy in eastern Africa. Two studies from Malawi and Uganda were community-based; two studies in Tanzania (urban Dar es Salaam and rural Haydom) were hospital-based. Clinical characteristics of PWE were assessed by the same questionnaire. Additionally, data on treatment were collected and computed tomography (CT) scans were performed. Overall, 1179 PWE were included in our analysis (581 (49.3%) female, median age 22 years (IQR 15-32 years)). Up to 25% of the patients had focal onset seizures. Those showed a higher rate of remarkable CT scan findings, with especially post-ischaemic and neurocysticercosis-associated lesions, compared to PWE with generalized onset seizures (35.1% vs. 20%). The majority of the patients experienced tonic-clonic seizures (70-85%). Only 67-78% of PWE received anti-seizure medication (ASM) treatment in the community-based studies, mostly monotherapy with phenobarbital, phenytoin or carbamazepine. Yet, underdosage was frequent and a large proportion of PWE received alternative non-ASM treatment consisting of herbal treatment (up to 83%) and/or scarification (up to 20%). Epilepsy is common in sub-Saharan Africa, often caused by neurocysticercosis or ischaemic strokes. PWE suffer from high seizure rates and subsequent injuries, as well as from socio-economic consequences due to insufficient ASM treatment. This pooled analysis illustrates the need for structural programmes for adequate identification, education, assessment and treatment of PWE in sub-Saharan Africa.
Sections du résumé
BACKGROUND
BACKGROUND
Epilepsy is one of the most common neurological disorders worldwide. Yet, its treatment gap is large in some areas and especially in sub-Saharan Africa data on clinical, radiological and semiological characteristics, as well as on treatment of persons with epilepsy (PWE) are still scarce.
METHODS
METHODS
We pooled data from four cross-sectional studies on epilepsy in eastern Africa. Two studies from Malawi and Uganda were community-based; two studies in Tanzania (urban Dar es Salaam and rural Haydom) were hospital-based. Clinical characteristics of PWE were assessed by the same questionnaire. Additionally, data on treatment were collected and computed tomography (CT) scans were performed.
RESULTS
RESULTS
Overall, 1179 PWE were included in our analysis (581 (49.3%) female, median age 22 years (IQR 15-32 years)). Up to 25% of the patients had focal onset seizures. Those showed a higher rate of remarkable CT scan findings, with especially post-ischaemic and neurocysticercosis-associated lesions, compared to PWE with generalized onset seizures (35.1% vs. 20%). The majority of the patients experienced tonic-clonic seizures (70-85%). Only 67-78% of PWE received anti-seizure medication (ASM) treatment in the community-based studies, mostly monotherapy with phenobarbital, phenytoin or carbamazepine. Yet, underdosage was frequent and a large proportion of PWE received alternative non-ASM treatment consisting of herbal treatment (up to 83%) and/or scarification (up to 20%).
CONCLUSIONS
CONCLUSIONS
Epilepsy is common in sub-Saharan Africa, often caused by neurocysticercosis or ischaemic strokes. PWE suffer from high seizure rates and subsequent injuries, as well as from socio-economic consequences due to insufficient ASM treatment. This pooled analysis illustrates the need for structural programmes for adequate identification, education, assessment and treatment of PWE in sub-Saharan Africa.
Identifiants
pubmed: 36028820
doi: 10.1186/s12883-022-02813-z
pii: 10.1186/s12883-022-02813-z
pmc: PMC9414166
doi:
Substances chimiques
Anticonvulsants
0
Carbamazepine
33CM23913M
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
321Subventions
Organisme : Bill and Melinda Gates Foundation
ID : 1017886
Organisme : Deutsche Forschungsgemeinschaft
ID : WI 3427/1-1
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022. The Author(s).
Références
Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18: 357–75. https://doi.org/10.1016/s1474-4422(18)30454-x .
Institute for Health Metrics and Evaluation (IHME) University of Washington. Global Burden of Disease Results Tool. https://vizhub.healthdata.org/gbd-results/ . Accessed 5 Feb 2020.
Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W, Schmutzhard E. Epilepsy and neurocysticercosis in rural Tanzania-An imaging study. Epilepsia. 2009;50:987–93. https://doi.org/10.1111/j.1528-1167.2008.01867.x .
doi: 10.1111/j.1528-1167.2008.01867.x
Kellinghaus C, Engbring C, Kovac S, et al. Frequency of seizures and epilepsy in neurological HIV-infected patients. Seizure. 2008;17:27–33. https://doi.org/10.1016/j.seizure.2007.05.017 .
doi: 10.1016/j.seizure.2007.05.017
Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology. 1988;38:1407–10. https://doi.org/10.1212/wnl.38.9.1407 .
doi: 10.1212/wnl.38.9.1407
Ngoungou EB, Preux P-M. Cerebral malaria and epilepsy. Epilepsia. 2008;49(Suppl 6):19–24. https://doi.org/10.1111/j.1528-1167.2008.01752.x .
doi: 10.1111/j.1528-1167.2008.01752.x
Ngoungou EB, Koko J, Druet-Cabanac M, et al. Cerebral malaria and sequelar epilepsy: first matched case-control study in Gabon. Epilepsia. 2006;47:2147–53. https://doi.org/10.1111/j.1528-1167.2006.00890.x .
doi: 10.1111/j.1528-1167.2006.00890.x
Pomeroy SL, Holmes SJ, Dodge PR, Feigin RD. Seizures and other neurologic sequelae of bacterial meningitis in children. N Engl J Med. 1990;323:1651–7. https://doi.org/10.1056/NEJM199012133232402 .
doi: 10.1056/NEJM199012133232402
Mushi D, Hunter E, Mtuya C, Mshana G, Aris E, Walker R. Social-cultural aspects of epilepsy in Kilimanjaro Region, Tanzania: knowledge and experience among patients and carers. Epilepsy Behav. 2011;20:338–43. https://doi.org/10.1016/j.yebeh.2010.11.016 .
doi: 10.1016/j.yebeh.2010.11.016
Viteva E. Impact of stigma on the quality of life of patients with refractory epilepsy. Seizure. 2013;22:64–9. https://doi.org/10.1016/j.seizure.2012.10.010 .
doi: 10.1016/j.seizure.2012.10.010
Ba-Diop A, Marin B, Druet-Cabanac M, Ngoungou EB, Newton CR, Preux PM. Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa. Lancet Neurol. 2014;13:1029–44. https://doi.org/10.1016/s1474-4422(14)70114-0 .
doi: 10.1016/s1474-4422(14)70114-0
Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia. 2010;51:883–90. https://doi.org/10.1111/j.1528-1167.2009.02481.x .
doi: 10.1111/j.1528-1167.2009.02481.x
Ibinda F, Odermatt P, Kariuki SM, et al. Magnitude and factors associated with nonadherence to antiepileptic drug treatment in Africa: A cross-sectional multisite study. Epilepsia Open. 2017;2:226–35. https://doi.org/10.1002/epi4.12052 .
doi: 10.1002/epi4.12052
Kariuki SM, Matuja W, Akpalu A, et al. Clinical features, proximate causes, and consequences of active convulsive epilepsy in Africa. Epilepsia. 2014;55:76–85. https://doi.org/10.1111/epi.12392 .
doi: 10.1111/epi.12392
Mbuba CK, Ngugi AK, Newton CR, Carter JA. The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia. 2008;49:1491–503. https://doi.org/10.1111/j.1528-1167.2008.01693.x .
doi: 10.1111/j.1528-1167.2008.01693.x
Wagner RG, Kabudula CW, Forsgren L, et al. Epilepsy care cascade, treatment gap and its determinants in rural South Africa. Seizure. 2020;80:175–80. https://doi.org/10.1016/j.seizure.2020.06.013 .
doi: 10.1016/j.seizure.2020.06.013
Cameron A, Bansal A, Dua T, et al. Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries. Epilepsia. 2012;53:962–9. https://doi.org/10.1111/j.1528-1167.2012.03446.x .
doi: 10.1111/j.1528-1167.2012.03446.x
Cameron A, Roubos I, Ewen M, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organ. 2011;89:412–21. https://doi.org/10.2471/blt.10.084327 .
doi: 10.2471/blt.10.084327
World Health Organization. Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders 2022–2031. Discussion paper, 2021. Stelzle D, Schmidt V, Keller L. Characteristics of People with Epilepsy and Neurocysticercosis in Three Eastern African Countries – a Pooled Analysis. PLOS NTD 2022; Currently under review
Schmidt V, O’Hara MC, Ngowi B, et al. Taenia solium cysticercosis and taeniasis in urban settings: Epidemiological evidence from a health-center based study among people with epilepsy in Dar es Salaam. Tanzania PLoS Negl Trop Dis. 2019;13:e0007751. https://doi.org/10.1371/journal.pntd.0007751 .
Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58:522–30. https://doi.org/10.1111/epi.13670 .
doi: 10.1111/epi.13670
Winkler AS, Schaffert M, Schmutzhard E. The pattern of epilepsy in a rural African hospital - an approach adapted to local circumstances. Trop Doct. 2009;39:44–7. https://doi.org/10.1258/td.2008.080057 .
doi: 10.1258/td.2008.080057
Owolabi LF, Adamu B, Jibo AM, et al. Prevalence of active epilepsy, lifetime epilepsy prevalence, and burden of epilepsy in Sub-Saharan Africa from meta-analysis of door-to-door population-based surveys. Epilepsy Behav. 2020;103:106846. https://doi.org/10.1016/j.yebeh.2019.106846 .
doi: 10.1016/j.yebeh.2019.106846
Sebera F, Munyandamutsa N, Teuwen DE, et al. Addressing the treatment gap and societal impact of epilepsy in Rwanda — Results of a survey conducted in 2005 and subsequent actions. Epilepsy Behav. 2015;46:126–32. https://doi.org/10.1016/j.yebeh.2015.03.028 .
doi: 10.1016/j.yebeh.2015.03.028
Sahlu I, Bauer C, Ganaba R, et al. The impact of imperfect screening tools on measuring the prevalence of epilepsy and headaches in Burkina Faso. PLoS Negl Trop Dis. 2019;13:e0007109. https://doi.org/10.1371/journal.pntd.0007109 .
doi: 10.1371/journal.pntd.0007109
Regesta G, Tanganelli P. Late-onset epilepsy and diffuse cryptogenous cerebral atrophy. Epilepsia. 1992;33:821–5. https://doi.org/10.1111/j.1528-1157.1992.tb02188.x .
doi: 10.1111/j.1528-1157.1992.tb02188.x
Woermann FG, Sisodiya SM, Free SL, Duncan JS. Quantitative MRI in patients with idiopathic generalized epilepsy. Evidence of widespread cerebral structural changes. Brain. 1998;121(P9):1661–7. https://doi.org/10.1093/brain/121.9.1661 .
Park KM, Kim SE, Lee BI, Hur YJ. Brain Morphology in Patients with Genetic Generalized Epilepsy: Its Heterogeneity among Subsyndromes. Eur Neurol. 2018;80:236–44. https://doi.org/10.1159/000496698 .
doi: 10.1159/000496698
Guerrini R, Carrozzo R. Epilepsy and genetic malformations of the cerebral cortex. Am J Med Genet. 2001;106:160–73. https://doi.org/10.1002/ajmg.1569 .
doi: 10.1002/ajmg.1569
Hunter E, Rogathi J, Chigudu S, et al. Prevalence of active epilepsy in rural Tanzania: a large community-based survey in an adult population. Seizure. 2012;21:691–8. https://doi.org/10.1016/j.seizure.2012.07.009 .
doi: 10.1016/j.seizure.2012.07.009
Esterhuizen AI, Carvill GL, Ramesar RS, et al. Clinical Application of Epilepsy Genetics in Africa: Is Now the Time? Front Neurol. 2018;9:276. https://doi.org/10.3389/fneur.2018.00276 .
doi: 10.3389/fneur.2018.00276
Camfield C, Camfield P. Injuries from seizures are a serious, persistent problem in childhood onset epilepsy: a population-based study. Seizure. 2015;27:80–3. https://doi.org/10.1016/j.seizure.2015.02.031 .
doi: 10.1016/j.seizure.2015.02.031
Tan M, Boston R, Cook MJ, D’Souza WJ. Risk factors for injury in a community-treated cohort of patients with epilepsy in Australia. Epilepsia. 2019;60:518–26. https://doi.org/10.1111/epi.14659 .
Newton CR, Garcia HH. Epilepsy in poor regions of the world. Lancet. 2012;380:1193–201. https://doi.org/10.1016/s0140-6736(12)61381-6 .
doi: 10.1016/s0140-6736(12)61381-6
Chin JH. Epilepsy treatment in sub-Saharan Africa: closing the gap. Afr Health Sci. 2012;12:186–92. https://doi.org/10.4314/ahs.v12i2.17 .
doi: 10.4314/ahs.v12i2.17
Kwon C-S, Wagner RG, Carpio A, Jetté N, Newton CR, Thurman DJ. The worldwide epilepsy treatment gap: A systematic review and recommendations for revised definitions - A report from the ILAE Epidemiology Commission. Epilepsia. 2022;63:551–64. https://doi.org/10.1111/epi.17112 .
doi: 10.1111/epi.17112
Chomba EN, Haworth A, Mbewe E, et al. The current availability of antiepileptic drugs in Zambia: implications for the ILAE/WHO “out of the shadows” campaign. Am J Trop Med Hyg. 2010;83:571–4. https://doi.org/10.4269/ajtmh.2010.10-0100 .
French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004;62:1252–60. https://doi.org/10.1212/01.wnl.0000123693.82339.fc .
doi: 10.1212/01.wnl.0000123693.82339.fc
Elafros MA, Bui E, Birbeck GL. Medication side effects among people with epilepsy taking phenobarbital in Zambia. Epilepsy Res. 2014;108:1680–4. https://doi.org/10.1016/j.eplepsyres.2014.08.005 .
doi: 10.1016/j.eplepsyres.2014.08.005
Nevitt SJ, Marson AG, Tudur Smith C. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev. 2019;7:CD001911. https://doi.org/10.1002/14651858.CD001911.pub4 .
doi: 10.1002/14651858.CD001911.pub4
Zhang L-L, Zeng L-N, Li Y-P. Side effects of phenobarbital in epilepsy: a systematic review. Epileptic Disord. 2011;13:349–65. https://doi.org/10.1684/epd.2011.0444 .
doi: 10.1684/epd.2011.0444
Keezer MR, Sisodiya SM, Sander JW. Comorbidities of epilepsy: current concepts and future perspectives. The Lancet Neurology. 2016;15:106–15. https://doi.org/10.1016/S1474-4422(15)00225-2 .
doi: 10.1016/S1474-4422(15)00225-2
Rai D, Kerr MP, McManus S, Jordanova V, Lewis G, Brugha TS. Epilepsy and psychiatric comorbidity: a nationally representative population-based study. Epilepsia. 2012;53:1095–103. https://doi.org/10.1111/j.1528-1167.2012.03500.x .
doi: 10.1111/j.1528-1167.2012.03500.x
Tellez-Zenteno JF, Patten SB, Jetté N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007;48:2336–44. https://doi.org/10.1111/j.1528-1167.2007.01222.x .
doi: 10.1111/j.1528-1167.2007.01222.x
M’bayo T, Tomek M, Kamara C, Lisk DR. Psychiatric comorbidity in African patients with epilepsy – Experience from Sierra Leone. Int J Epilepsy. 2017;4:26–30. https://doi.org/10.1016/j.ijep.2016.12.002 .
doi: 10.1016/j.ijep.2016.12.002
Berg AT, Altalib HH, Devinsky O. Psychiatric and behavioral comorbidities in epilepsy: A critical reappraisal. Epilepsia. 2017;58:1123–30. https://doi.org/10.1111/epi.13766 .
doi: 10.1111/epi.13766
Knauss S, Stelzle D, Emmrich JV, Korsnes MS, Sejvar JJ, Winkler AS. An emphasis on neurology in low and middle-income countries. Lancet Neurol. 2019;18:1078–9. https://doi.org/10.1016/S1474-4422(19)30392-8 .
doi: 10.1016/S1474-4422(19)30392-8
World Health Organization. Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders 2022–2031. Discussion paper. 2021. https://cdn.who.int/media/docs/defaultsource/mental-health/english_discussion-paper_epilepsy-and-other-neurological-disorders_050321.pdf?sfvrsn=eec245a2_96&download=true .